- Recent Funding
- Investors
- RTW Investments
RTW Investments portfolio
RTW Investments has 6 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
It is a venture capital firm based in New York, US, founded in 2009. It led 1 of the 6 rounds it joined. Its most recent investment on record is Neurosterix's $105M Series B+ round in November 2026, which it led. By category, its portfolio leans toward Health and bio (6) and Manufacturing and industrial (1). It has co-invested with SR One, SoftBank Vision Fund and Cormorant Asset Management, most often SR One (2 rounds).
About RTW Investments
What RTW Investments invests in
- Health and bio · 6 · 100%
- Manufacturing and industrial · 1 · 17%
- Data and analytics · 1 · 17%
RTW Investments recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $105M · lead | none named | ||
| Series B+ · $287M | SilverArc Capital, Hengdian Group, Adage Capital Management +6 | ||
| Series B+ · $100M | DCVC Bio (lead), Emerson Collective, Qiming Venture Partners USA +6 | ||
| Series A · $200M | Novo Holdings (lead), Qiming Venture Partners, SR One +5 | ||
| Series A · $400M | ARCH Venture Partners (lead), Fidelity Management & Research Company, Farallon Capital Management +5 | ||
| Series B+ · $210M | DCVC Bio, Emerson Collective, Qiming Venture Partners USA +6 |
How RTW Investments invests
RTW Investments portfolio companies
NNeurosterix$105MSeries B+ · Nov 2026
CCorxel$287MSeries B+ · Jan 2026UUmoja Biopharma$100MSeries B+ · Jan 2025
WWindward Bio$200MSeries A · Jan 2025
MMirador Therapeutics$400MSeries A · Mar 2024
EEnsomabacker
| Company | Round with RTW Investments | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $105M · lead | $168M | Nov 13, 2026 Series B+ |
Health and bio |
Series B+ · $287M | $287M | Jan 26, 2026 Series B+ |
Health and bio |
Series B+ · $100M | $363M | Jan 14, 2025 Series B+ |
Health and bio |
Series A · $200M | $200M | May 5, 2026 round |
Health and bio |
Series A · $400M | $650M | Jan 13, 2026 Series B+ |
Health and bio |
backer | $50M | May 16, 2023 Series B+ |
Most frequent co-investors
SSR One2 shared rounds · last Jan 26, 2026
SSoftBank Vision Fund2 shared rounds · last Jan 14, 2025
CCormorant Asset Management2 shared rounds · last Jan 14, 2025
EEmerson Collective2 shared rounds · last Jan 14, 2025
DDCVC Bio2 shared rounds · last Jan 14, 2025
MMPM Capital2 shared rounds · last Jan 14, 2025
QQiming Venture Partners USA2 shared rounds · last Jan 14, 2025
OOrbiMed2 shared rounds · last Jan 10, 2025
IInvus1 shared round · last Jan 26, 2026
RRA Capital Management1 shared round · last Jan 26, 2026
SSymBiosis1 shared round · last Jan 26, 2026
AAdage Capital Management1 shared round · last Jan 26, 2026
Similar investors
HHealthier Capital6 companies · 4 deals in 12 mo
UUC Investments6 companies · 4 deals in 12 moAAbingworth6 companies · 3 deals in 12 mo
HHBM Healthcare Investments6 companies · 3 deals in 12 mo
TThe FSE Group6 companies · 3 deals in 12 mo
TThird Rock Ventures6 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 6 rounds on Recent Funding that name RTW Investments. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists RTW Investments, which is a subset of its real portfolio. API: /api/v1/investors/rtw-investments (get a free API key). More: the most active VC firms and new venture capital funds.